Skip to main content

FDA Delays Decision Over Juul's Vaping Products

FDA Delays Decision Over Juul's Vaping Products

FDA Delays Decision Over Juul's Vaping Products

Introduction

The officials of the Food & Drug Administration (FDA) of the United States delayed the decision of Juul vaping products that would decide the fate of the product in the U.S. market.

FDA banned thousands of electronic cigarettes and related products to prevent underage smoking, but the agency did not rule on Juul, which is the most popular brand among adults and teens. The agency has been repeatedly pressurized by parents, politicians and anti-tobacco advocates to ban the Juul vaping products, but the officials stated they need sufficient time and evidence to proceed.

Companies manufacturing e-cigarettes need to provide precise data about the benefits of the products to public health how they will help to reduce or quit smoking among heavy smokers and prevent smoking addiction among the underage. The companies might be able to survive in the market if they manage to provide such data.

Attorneys for the plaintiffs and families of the affected people are outraged because of the delay in the decision. They even showed concern about the growing addiction problem among teens.

E-cigarettes were introduced in the U.S. market a decade ago to provide a less harmful alternative to smokers. But as per the industry experts, the products did not serve the purpose and fueled nicotine addiction among the teens and adults who smoke.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.